Skip to main content
Caplight Logo









Scanvio Medical

Scanvio Medical

Private
ZurichHealthcare & Life Scienceshttps://www.scanvio.com/

Last Round

Seed

Jul 15, 2025

Total Funding Raised

$3.62M

Company Overview

Scanvio Medical is a medical technology company that develops AI-augmented ultrasound software to assist gynecologists in the early and accurate diagnosis of endometriosis.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Medical Devices, Computer Vision

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware + Subscription

AI Layer

Application

Keywords

medical AIultrasound AIendometriosis diagnosissoftware-as-a-medical-deviceSaMDcomputer visionmedical imagingAI diagnosticsclinical decision supportmedtechAI ultrasounddigital healthAI-assisted surgerysmart ultrasound

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Scanvio Medical Comparables

Compare Scanvio Medical with similar companies based on industry and business-model similarity.

Scanvio Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Revela Health
85%
EndoCure
82%
ThinkSono
73%

Scanvio Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 15, 2025
GrantFeb 7, 2025
GrantJul 15, 2024
GrantMay 21, 2024

Key People

Founding team and executive leadership

Stefan Tuchschmid

CEO and Founder

Founding Team

Fabian Laumer

CTO

Executive Team

Scanvio Medical Investors

Notable investors and investment history

Scanvio Medical investors
InvestorRounds
KickfundSeed
SuperangelsSeed
Swiss ICT Investor ClubSeed
Venture KickSeed, Grant
S2S VenturesSeed
StartAngels NetworkSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 5, 2026

    Monthly visitors grew 100% MoM, reaching 1.8K.

  • Nov 14, 2025

    Grew 36% QoQ, from 11 to 15 employees.

Scanvio Medical Filings

Explore SEC and related filing metadata, where available.

Scanvio Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Scanvio Medical's valuation, stock price, and market status.

Is Scanvio Medical a public or private company?

Scanvio Medical is a private company.

What is the current stock price of Scanvio Medical?

Scanvio Medical is a private company with no public stock price. No recent secondary market data is available.

How much is Scanvio Medical worth (valuation)?

Valuation information for Scanvio Medical is not publicly available.

Can I buy Scanvio Medical stock?

Scanvio Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Scanvio Medical's last funding round?

Scanvio Medical's most recent funding round was Seed on July 15, 2025.

Who are the main investors in Scanvio Medical?

Key investors in Scanvio Medical include Venture Kick.

Will Scanvio Medical IPO soon?

No public IPO plans have been announced for Scanvio Medical.

How can I track Scanvio Medical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Scanvio Medical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersZurich
Employee Range14
Year Founded2024
Last FundingJul 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?